# Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee

> **NCT01251588** · — · COMPLETED · sponsor: **Vericel Corporation** · enrollment: 128 (actual)

## Conditions studied

- Articular Cartilage Defects

## Interventions

- **BIOLOGICAL:** autologous cultured chondrocytes on porcine collagen membrane
- **PROCEDURE:** Microfracture

## Key facts

- **NCT ID:** NCT01251588
- **Lead sponsor:** Vericel Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01251588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01251588, "Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01251588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*